BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Small Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2158.56 only $1079.28

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,037.26
0.64%
US Tech 100
20,508.40
0.58%
Dow Jones
44,765.99
-0.32%
Brent Oil
71.945
-0.18%
Bitcoin
96,359.01
-0.93%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. CSE

  6. Kal Minerals Corp (KAL) Quote

Kal Minerals Corp

Kal Minerals Corp (KAL)

Kalgoorlie Gold Mining Ltd
0.14
0.00
( 0.00% )
Updated: 19:00:00
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.14
Bid
0.135
Ask
0.40
Volume
-
0.00 Day's Range 0.00
0.14 52 Week Range 0.14
Previous Close
0.14
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

KAL Latest News

More News

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

September 20 2007
PR Newswire (US)

American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

August 29 2007
PR Newswire (US)

Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines

Plaintiff claims suffered damages in Korean Air Lines price fixing conspiracy SEATTLE, Aug. 10 /PRNewswire/ -- Seattle-based law firm Hagens Berman Sobol Shapiro filed a class action lawsuit...

August 10 2007
PR Newswire (US)

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and inflammatory diseases...

August 09 2007
PR Newswire (US)

Callisto Reports on Second-Quarter 2007 Milestones

Company Cites Continuing Progress on Clinical and Preclinical Programs NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug...

August 08 2007
PR Newswire (US)

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

August 07 2007
PR Newswire (US)

Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health threats...

June 25 2007
PR Newswire (US)

Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company focused on the development of new drugs to treat cancer and...

June 08 2007
PR Newswire (US)

Callisto Pharmaceuticals Opens Fourth Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, May 24 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drugs for the treatment of cancer and inflammatory diseases, announced today...

May 24 2007
PR Newswire (US)

Callisto Pharmaceuticals Announces Article Citing Atiprimod in Major Scientific News Journal

History of Atiprimod Appears in Genetic Engineering & Biotechnology News NEW YORK, May 15 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical...

May 15 2007
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.140.140.1400CS
4000.140.140.1400CS
12000.140.140.1400CS
26000.140.140.1400CS
52000.140.140.1400CS
156000.140.140.1400CS
2600.015120.1250.160.0816460.12148515CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BULLQuest Critical Metals Inc
$ 0.12
(100.00%)
46k
FNQFineqia International Inc
$ 0.01
(100.00%)
1,000
CRPCCritical Reagent Processing Corp
$ 0.01
(100.00%)
24k
SANUSanu Gold Corp
$ 0.095
(90.00%)
2.08M
MLKMMayo Lake Minerals Inc
$ 0.035
(75.00%)
15k
WINCommon Stock
$ 0.005
(-50.00%)
27.4k
IANiAnthus Capital Holdings Inc
$ 0.005
(-50.00%)
5.22k
MYCOMydecine Innovations Group Inc
$ 0.005
(-50.00%)
1.18k
LOBELobe Sciences Ltd
$ 0.01
(-50.00%)
1.25k
NXTNextGen Digital Platforms Inc
$ 0.05
(-44.44%)
1.67k
SANUSanu Gold Corp
$ 0.095
(90.00%)
2.08M
IAIinfinitii ai inc
$ 0.055
(22.22%)
814.76k
MILIMilitary Metals Corp
$ 0.40
(2.56%)
547.89k
MECMustang Energy Corp
$ 0.395
(2.60%)
400.57k
AIMLAl ML Innovations Inc
$ 0.10
(-4.76%)
276.73k

Discussion

View Full Feed
02opida 02opida 1 minute ago
Monday Morning ~ Coffee ~ Tea Everyone
JettaR JettaR 1 minute ago
Nothing on news page since September. Tells us what? 
RGLG
PEACHMAN PEACHMAN 1 minute ago
Impact Fusion International Expands Marketing for Supreme AG™
Scientific Testing / Supreme AG™

a. Where SGP+™ utilizes sugarcane bagasse as an ingredient, Supreme AG™
is NOT unrefined bagasse.
b. Processed with native minerals and other naturally occurring substan
IFUS
tedpeele tedpeele 1 minute ago
finally a chance to move to a new level.
RDAR
Iggy_Bot Iggy_Bot 1 minute ago
Im surprised this morning the repubs didn't file for impeachment
Golden Cross Golden Cross 1 minute ago
$ILLR News ⬇️⬇️⬇️
https://trillercorp.com/creator-centric-triller-sean-kims-strategy-for-social-platform-success/
ILLR
jay_tee jay_tee 1 minute ago
The sad thing is Seamus has stated in his yearly letter to shareholders for ten years that he will bring value to us. I've learned the hard way to take that statement with a grain of salt. Maybe if I toss that salt over my shoulder??? Hmmmm... that might actually work....
RNVA
FACT-MASTER FACT-MASTER 2 minutes ago
SIZZZZl'ing

ASK gett'in annihilated!
ESPR
Idiot Mayor Idiot Mayor 2 minutes ago
Dead cat bounce coming?
ACHR
02opida 02opida 2 minutes ago
Good Post BDEZ
gp22 gp22 2 minutes ago
$MTEK @ $2.20s: Last AI Drone play to rip on volume. A sitting duck right now. Float 4.3M
MTEK
Monroe1 Monroe1 2 minutes ago
Could be a visit to the optometrist is in order.
NBRI
m0n m0n 2 minutes ago
Wishful thinking & Hypotehtical nonsense.

No One is Fooled 
IFUS
Krombacher Krombacher 2 minutes ago
SSC, your recent posts continue to misrepresent facts and recycle unfounded claims. Let's address your points systematically:

1. "Any Day Now" Predictions:
You mock the phrase "any day now," referencing a past sticky post about a deal with Total. While the timeline was longer t
ERHE
gp22 gp22 3 minutes ago
$MTEK @ $2.20s: Last AI Drone play to rip on volume. A sitting duck right now. Float 4.3M
MTEK
Carjockey2 Carjockey2 3 minutes ago
Wowza!!!@@
konshe konshe 3 minutes ago
When we get PPS at 0.30?
ASII
Twilson Twilson 3 minutes ago
You going short on WMT?
WMT
georgie18 georgie18 3 minutes ago
XPON...$2.39...🥳...

georgie18

Member Level
Re: georgie18 post# 254

Tuesday, November 26, 2024 11:37:30 AM

Post#
255
of 256
XPON...$2.30...Small floater...Looking for a bottom Squeeze here...🥳..
XPON
gp22 gp22 3 minutes ago
$MTEK @ $2.20s: Last AI Drone play to rip on volume. A sitting duck right now. Float 4.3M
MTEK
firebag1 firebag1 3 minutes ago
2 fitty!
RDAR
georgie18 georgie18 3 minutes ago
XPON...$2.39...🥳...

georgie18

Member Level
Re: georgie18 post# 254

Tuesday, November 26, 2024 11:37:30 AM

Post#
255
of 256
XPON...$2.30...Small floater...Looking for a bottom Squeeze here...🥳..
XPON
learningcurve2020 learningcurve2020 3 minutes ago
She conned MHRA style="font-size: 1em" into what, allowing her to submit an application?  JAMA simply reported on the Plll outcome with no recommendation. The integrity of the data relies on Bosch.  Countless MD's? BP partners? You're hallucinating again.  
NWBO
IAmTopG IAmTopG 3 minutes ago
Everytime I have hopes that it would keep going up, someone crashed this back down. Thought this would break $3 smh
GMGI

Your Recent History

CSE
KAL
Kal Minerals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32